SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders. It has applied ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback